word,tfidf
m12,2.108180733889807
m6,1.786220454727271
m24,1.7233995811503136
defined,1.6992938778243725
response,1.6290827872141014
m3,1.5513446797893704
day,1.5138024156249166
months,1.456541311700484
12,1.454307947552154
week,1.4231442307290603
incidence,1.3970015357383616
gvhd,1.1889929999761855
according,1.0912507421240722
treatment,1.0714339455523505
grade,1.0461451947757494
relapse,0.971860171426064
time,0.9559985868035807
days,0.938694092240631
criteria,0.9034091002542282
m1,0.8897918897649918
post,0.8858110072375074
inclusion,0.8793581521891827
rate,0.8791928148373067
remission,0.8735421416426776
24,0.8559178572470344
16,0.8542510896610348
events,0.8183398510238842
using,0.7872077166048153
disease,0.7854311520107827
patients,0.7847418931692748
baseline,0.7771096029287109
analysis,0.7726300312008726
clinical,0.7715924331423915
compared,0.7554893187136792
hospitalization,0.7512147224304605
transplantation,0.7394817161867387
21,0.7369013671160822
survival,0.7273295151989919
cardiac,0.7145958024320698
48,0.6748122331622757
month,0.6711856728034195
following,0.6690533245581944
transplant,0.6594295496310154
vascular,0.6528860917888017
new,0.6489106420934322
overall,0.6422141017409234
assessed,0.6382269621577801
number,0.6271519753437033
adverse,0.6248335851342862
secondary,0.6234366965533733
endpoint,0.6202587171678619
chronic,0.6181241351549281
primary,0.614449803030504
follow,0.6141022782288786
blood,0.6019354813728773
non,0.5903244436982392
lesions,0.5878581177365957
cells,0.5865429906559769
m0,0.5854683230864342
weeks,0.5849434132920134
100,0.5773845400659509
complete,0.5759739087842644
progression,0.5755613663711657
acute,0.5610394923169206
severe,0.5504078053214235
pga,0.5479970319250981
best,0.5476764578829691
evaluated,0.5418077398784679
m9,0.541259516149863
36,0.540835876654332
eye,0.5383560852449678
scale,0.5101873779482634
failure,0.5095277868302651
rates,0.5069543178270617
90,0.5064066939367274
standard,0.49643312954381325
22,0.4951980032124797
20,0.49260826919624584
platelets,0.4846169557965797
prednisone,0.48095703769965364
date,0.4807375976911986
result,0.47816346622802797
score,0.4753413763796315
toxicity,0.4745996089900189
life,0.47270344573991774
function,0.47020771256209953
study,0.46914089078898247
syndrome,0.46648602994935706
30,0.4612428489436432
lung,0.46048500495260475
safety,0.45813660999336125
quality,0.45734646366815146
estimated,0.4565234743617059
cell,0.450940237156662
actg,0.45058268031629767
performed,0.4453333598681852
neutrophils,0.4411344857614008
changes,0.4405977101289753
engraftment,0.43820557137892063
retinal,0.43716616459240765
chimerism,0.4355906871199204
improvement,0.4296424040090164
randomization,0.4261811428417683
arm,0.4256230669320465
consecutive,0.42159663901811195
anti,0.41813960738194855
dose,0.4020447421026692
related,0.39973659443745124
infusion,0.3952412555243953
endpoints,0.39297602591064673
informative,0.3919429979789691
occurrence,0.38854739303527447
free,0.3859173100064637
mean,0.3800413376104585
25,0.3729956504147668
vasculitis,0.3649209196765796
proteinuria,0.36335376324056196
increase,0.36264461881451715
graft,0.35581820564305366
visit,0.3481016040547483
levels,0.347832095687712
efficacy,0.34567740953599346
clinically,0.3454823711648397
composite,0.34239387704235286
tumor,0.3411568505746509
priors,0.3396904217611647
central,0.3395308462413243
treatments,0.3377156610234723
grading,0.33583248111779085
reappearance,0.3345936584055423
ctcae,0.3319952784060742
19,0.33184784376637716
renal,0.33114439459138434
event,0.3311209541076748
questionnaire,0.3294003233678646
kidney,0.32907810780217933
resolution,0.3263463324629857
mg,0.32611265913453036
beta,0.3230424764439377
partial,0.32257258026184377
evaluation,0.32248880320265144
models,0.32227289635522993
normalization,0.3213206196569664
injection,0.3190818362233377
transfusions,0.3189802662343936
mri,0.3170874287250073
msc,0.3161795352460668
transfusion,0.310690593510709
lymphocytes,0.31005599549867624
change,0.3046584214115392
immune,0.303874656952549
reading,0.3037610375185622
centralized,0.3037610375185622
appendix,0.3032116490275267
parameters,0.30031489713794995
pre,0.2999092093790783
blinded,0.2973272125677542
level,0.2952657293708933
health,0.294330779864204
target,0.2931354447488299
start,0.2927643354005811
recorded,0.2927643354005811
haze,0.29137148718845307
ventricular,0.2905420043036151
classification,0.28834593260283137
analyses,0.28697974544005495
considered,0.2841605651211364
reconstitution,0.28413338589600723
disappearance,0.2819870451151232
glomerular,0.2812161401627872
severity,0.2802955982238334
nk,0.2789489450143552
sf,0.27756801104436823
filtration,0.2760246632633933
specific,0.27436380368619095
mortality,0.27330393524053087
creatinine,0.2732674080751138
infection,0.273060513914423
platelet,0.273060513914423
thickness,0.2704727126978622
definition,0.2697208963431503
worsening,0.2689928131335053
section,0.26854350151456424
cd,0.26756598948180277
end,0.26741553849101257
imaging,0.2663086044462998
activity,0.265516839322013
50,0.26479667225603265
mdrd,0.26432693620183695
60,0.26389631001046004
therapy,0.26286203892205684
serum,0.25885816125217287
cumulative,0.25869041040329877
borr,0.2548615871762682
occurs,0.2544246596174063
prednisolone,0.25430966869181076
infections,0.24971266291074395
sct,0.2486957534925523
including,0.2484046272579012
involvement,0.24799597706921775
neutrophil,0.24795601942960624
cause,0.2457907839320425
appearance,0.24379346291584464
leukemic,0.24196745462684424
visual,0.23996950752210824
left,0.23969001132215706
vitreous,0.23952486175461762
arms,0.23913052245996763
decrease,0.23903088907791128
steroids,0.23733024880304826
macular,0.23559492297595885
iv,0.23539252542755407
proportion,0.2300562362884802
documented,0.2270050661058829
ii,0.22696910552369448
ks,0.22529134015814883
expression,0.22454521519922593
laboratory,0.22368679077171993
toxicities,0.2216653053347189
measures,0.21992949938610645
assessment,0.2156815813931182
m2,0.2153583916950137
bcva,0.21481766295844285
underlying,0.21481766295844285
anterior,0.21481766295844285
chamber,0.21481766295844285
samples,0.21434935472693792
ct,0.21414463047348237
active,0.21361130930621125
percentage,0.21323502684605136
index,0.21253835311461033
death,0.2116620638151204
10,0.20987703182184433
maximum,0.20980665689383543
cd8,0.20966184246273806
cd4,0.20966184246273806
year,0.20842773154673389
bayesian,0.20824072478250966
discontinuation,0.20655016448135308
ctae,0.20580935050418256
cancer,0.2044381671627153
scan,0.20078272577001438
hours,0.19961868621662815
symptoms,0.19955417262796896
hsct,0.1992847570292522
numbers,0.19868487574102384
measured,0.19844511054105693
kg,0.197462468255846
et,0.19605848513852303
al,0.19605848513852303
red,0.19590507623334014
absence,0.19590189491370877
refractory,0.1955485923162964
independent,0.1948740143756546
surface,0.19472469589656588
pcr,0.19444060314418232
count,0.19434214424491086
v5,0.1932986414311076
requiring,0.19167608453232715
peripheral,0.19138541000405696
case,0.19076471319605126
equal,0.18846303741432888
bd,0.1882680112788436
behcets,0.1882680112788436
normal,0.18764752633087103
corticosteroid,0.18737396040237933
beginning,0.18701748258558715
ferritin,0.18628719293259466
dna,0.1862713576266643
prior,0.18540970480739122
uniform,0.18370227319645938
binomial,0.18370227319645938
alive,0.18358269619684903
grfs,0.18352730820034388
confirmed,0.18310088992877616
collection,0.1828538478143923
interval,0.1828452905416793
described,0.18148213332951665
associated,0.17992583492427
moderate,0.17861770708522307
markers,0.17713385642661544
having,0.1755866846022603
plasma,0.17422199254972087
early,0.17404681309306114
biological,0.1729265876287549
concentration,0.1722116571186849
subjects,0.17156203989455654
increased,0.17085700710844404
patient,0.17069486289619967
evidence,0.17012926411542323
value,0.169346031552543
magic,0.16925156614431658
nih,0.16925156614431658
frequency,0.16859959967516677
tolerability,0.16859959967516677
recurrence,0.16816141030787485
ctc,0.16790641374150966
ebv,0.167504611916157
cmv,0.167504611916157
flare,0.16688706302499734
protein,0.1666413101108869
reactive,0.1666413101108869
biologically,0.16549266013005787
delay,0.1625173805667974
sparing,0.1617091804543855
hemolytic,0.16038256481503743
150,0.1603519465058274
rectal,0.1603519465058274
duration,0.158590474814361
nci,0.15846359061923798
donor,0.15816386116340458
absolute,0.15783773298809928
uveitis,0.15759380893804198
manifestations,0.15588295297410779
cost,0.1550986051779612
gammaglobulines,0.1550535848103928
drug,0.15404738704176363
iii,0.15385932249716336
randomized,0.15285996486060072
estimator,0.15281247551900146
ssc,0.1513958998413083
meeting,0.15090525891879308
targets,0.15090525891879308
percent,0.15090525891879308
edema,0.15090525891879308
years,0.15012123475160538
right,0.14971096298923187
sae,0.14963680247329764
included,0.14906786543737494
5g,0.1489585390576148
phase,0.1488572966801505
counts,0.14856352054282018
microns,0.1477807471482305
coherence,0.1477807471482305
oct,0.1477807471482305
optical,0.1477807471482305
300,0.1477807471482305
features,0.1466573847755877
analyzed,0.14603407102920346
trial,0.14598798206368302
data,0.1456083224531442
ae,0.1446768292699461
hospital,0.14377025269404325
fever,0.14318088096506315
inflammatory,0.14293614831126278
systemic,0.14253569734943908
use,0.14235941255891865
organs,0.1412228428278549
nervous,0.14116975395728676
limited,0.14114907525556736
qlq,0.13942882311511628
factors,0.13942882311511628
v3,0.13942882311511628
c30,0.13942882311511628
eortc,0.13942882311511628
digestive,0.1391594185262508
sun,0.137991739024926
24h,0.13746704862063386
skin,0.1373699158444452
analyzing,0.1372291647745848
group,0.1367470560142551
length,0.1367470560142551
adapted,0.13638233047976747
investigator,0.13618230502577802
point,0.13585537046547114
acuity,0.13553071165270444
corrected,0.13553071165270444
pulmonary,0.13552572421620931
medical,0.13436283282112252
gastrointestinal,0.13432706822467616
biopsy,0.13424151174832458
measure,0.13411577150118156
second,0.134102982100775
interaction,0.13385652223560446
test,0.13198077636880617
min,0.13194621190626185
physical,0.13177063328870678
form,0.13168391248396674
profile,0.13100146460254372
main,0.13100057670583168
total,0.12955149633132326
relapses,0.12954971137030075
consumption,0.12934145323037977
ocular,0.12930667795269202
2016,0.12926861047140661
consortium,0.12926861047140661
resonance,0.12868303848359872
magnetic,0.12868303848359872
physician,0.12859426170940041
impact,0.12800121767499875
course,0.12757204919705756
involved,0.1270167661460995
myeloid,0.12697187982369107
clinic,0.12668627080857198
version,0.12668627080857198
evolution,0.12569136190224953
previous,0.1252982986723648
crp,0.12432167288949988
bone,0.12404565127603656
med,0.1238796505257162
amplification,0.12356307021622438
chest,0.12342224008471858
effects,0.1231328646113948
18,0.12305663658773866
clearance,0.12245221535855447
hematopoietic,0.1221158920721106
line,0.1221158920721106
regulatory,0.1221158920721106
courses,0.1221158920721106
38,0.12202208271730801
gamma,0.12194350241302161
responder,0.12161005101158624
step,0.12126589379509847
cerebral,0.12086755305434338
lymphocyte,0.12050090828650525
meier,0.11797742470713188
kaplan,0.11797742470713188
criterion,0.1179648271592387
virological,0.11712924526541632
sample,0.11712924526541632
quantification,0.11712924526541632
47,0.11664024060273077
treated,0.11625683481182345
terminology,0.11577260339599861
common,0.11577260339599861
presence,0.11518852816545178
qol,0.11512347688410185
body,0.11493081881208547
additional,0.11358305129989689
extensive,0.11296059685065843
discretion,0.11257741453420575
acquired,0.11143745054001039
anemia,0.11143745054001039
monitoring,0.11119902021733388
results,0.11119902021733388
terms,0.11046976744046384
lymphedema,0.11046976744046384
ctep,0.11046976744046384
gov,0.11046976744046384
scored,0.11046976744046384
censored,0.10993211086967238
usual,0.10842183296068278
unblinded,0.10683093522578231
based,0.10554920408059935
creatininuria,0.10517181175033039
preexisting,0.10431012630012348
status,0.1040171513995121
abdominal,0.1033627889012135
arthritis,0.10316147631929444
pains,0.10316147631929444
endoscopy,0.10316147631929444
collected,0.10292060887341914
present,0.10246027818442695
care,0.10234979687979168
considering,0.10118690548470488
inflammation,0.10086379199334022
rank,0.10055989930119709
loss,0.10018436281882165
chosen,0.09984447452893876
distribution,0.09926793128890543
observed,0.0991433236235039
intervals,0.0991433236235039
initiation,0.09858058564652081
troponin,0.09832912601771979
neurological,0.09832912601771979
allo,0.0980292607052354
survey,0.09775074141262888
potential,0.09753843647517685
unit,0.09736234794828294
achieving,0.09722030157209116
echocardiography,0.09550711114718106
modified,0.09438018004963684
reduction,0.09433163990341428
steroid,0.09389531746867408
attacks,0.09378149481139908
organization,0.09378149481139908
international,0.09378149481139908
world,0.09378149481139908
tolerated,0.09378149481139908
toxic,0.09378149481139908
degree,0.09378149481139908
gammaglobulin,0.09369173881015763
complications,0.09369173881015763
250,0.09365964261163004
tomography,0.0931242739760003
95,0.09283410633809738
trials,0.09262637716077256
extra,0.09252884741507084
onset,0.0913043764602261
pain,0.0908343621694078
different,0.09052643379036603
define,0.08941340981984752
scales,0.08825051842476073
need,0.08824957812401132
investigators,0.08759688519139408
electrolytes,0.08759688519139408
stage,0.08641821941838589
determined,0.08528921264366272
curve,0.08528921264366272
treat,0.08501043158031625
mass,0.08376938007877009
enzymes,0.08301329727805742
neuropathy,0.08301329727805742
follows,0.08185040588297064
allogeneic,0.08172579821756912
perform,0.08160394601780008
thoracic,0.08019128240751872
bilirubin,0.08019128240751872
volume,0.08019128240751872
immunological,0.07709701109528785
nephritis,0.07648857707086582
values,0.0763639694054643
reasons,0.07541658093216258
fact,0.07511132200913606
phosphatase,0.07375745745671067
liver,0.07375745745671067
gt,0.07375745745671067
alkaline,0.07375745745671067
highest,0.07314453439474178
current,0.07314453439474178
reactants,0.07314453439474178
paraclinical,0.07314453439474178
bilateral,0.07314453439474178
esr,0.07314453439474178
sub,0.07310890838443124
detection,0.07310890838443124
measurement,0.07174712202567471
17,0.07174712202567471
tnfa,0.07174712202567471
stored,0.07144978490897931
used,0.07144978490897931
reaction,0.07144978490897931
angiography,0.06969306712111417
tyndall,0.06969306712111417
leakage,0.06969306712111417
vessel,0.06969306712111417
weight,0.06801097814828723
points,0.06774707957232641
ulcers,0.06716353411233808
affected,0.06716353411233808
seen,0.06716353411233808
remissions,0.06716353411233808
articular,0.06716353411233808
previously,0.06600064271725128
doubling,0.06547116420672112
1g,0.06547116420672112
hematuria,0.06547116420672112
complement,0.06547116420672112
c4,0.06547116420672112
corticosteroids,0.06547116420672112
judgment,0.06547116420672112
intent,0.06443288047703585
sponsor,0.06443288047703585
consider,0.06443288047703585
combined,0.06443288047703585
hla,0.06430827281163433
daily,0.06430827281163433
antibodies,0.06430827281163433
positive,0.06430827281163433
short,0.06430827281163433
36v2,0.06430827281163433
urine,0.0626491493361824
aggravation,0.0626491493361824
paris,0.0626491493361824
cytokines,0.0626491493361824
ansm,0.0626491493361824
continuous,0.06254917544362368
control,0.06089005196817175
committee,0.0579990555262278
activation,0.05569138297849645
cytometry,0.05569138297849645
assess,0.05569138297849645
global,0.05569138297849645
include,0.05569138297849645
doses,0.04689074740569954
